Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
G. Petrova (Sofia, Bulgaria), D. Miteva (Sofia, Bulgaria), T. Strateva (Sofia, Bulgaria). Myroides odorarus another one from the new emerging pathogens in cystic fibrosis – case report. 688

Member's Comments

No comment yet.

Related content which might interest you: Achromobacter (A.) xylosoxidans in cystic fibrosis: prevalence and clinical relevance Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle Year: 2005 Cystic fibrosis microbiology, emerging pathogens and more treatment options Source: International Congress 2018 – PG10 Cystic fibrosis: Basic defects and clinical problems in children Year: 2018 Emerging pathogens in cystic fibrosis Source: International Congress 2019 – State of the art session: Paediatric respiratory diseases Year: 2019 Molecular epidemiological analysis suggests cross-infection with Pseudomonas aeruginosa is rare in non-cystic fibrosis bronchiectasis Source: Eur Respir J 2014; 43: 900-903 Year: 2014 Cystic fibrosis infection with clonal strains of Pseudomonas aeruginosa: current knowledge and future management Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=105 Year: 2006 Emerging pathogens in cystic fibrosis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=66 Year: 2006 Systemic quorum sensing signal molecules are biomarkers for current and future P. aeruginosa infection in cystic fibrosis patients: A longitudinal study Source: International Congress 2015 – Cystic fibrosis: assessment and treatment Year: 2015 The spectrum of Nocardia lung disease in cystic fibrosis Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous Year: 2015 Current concepts: host–pathogen interactions in cystic fibrosis airways disease Source: Eur Respir Rev 2014; 23: 320-332 Year: 2014 Biofilms and how to combat them: examples from cystic fibrosis Source: Virtual Congress 2020 – Antibiotic resistance: the way forward Year: 2020 Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients Source: Eur Respir J 2008; 31: 822-829 Year: 2008 Effective strategies for managing new Pseudomonas cultures in adults with cystic fibrosis Source: Eur Respir J 2015; 46: 862-865 Year: 2015 Fungi communities detected by metagenomic tools in sputum in patients with cystic fibrosis Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013 The identification of bacterial strains in specimens of adult cystic fibrosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 49s Year: 2004 Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections Source: Eur Respir J 2012; 40: 227-238 Year: 2012 Epidemiological-molecular study of colonization by pseudomonas aeruginosa in cystic fibrosis patients Source: Eur Respir J 2002; 20: Suppl. 38, 379s Year: 2002 Epidemiology of Burkholderia cepacia complex colonisation in cystic fibrosis patients Source: Eur Respir J 2004; 23: 851-856 Year: 2004 Host specificity of pseudomonas aeruginosa isolates from patients with cystic fibrosis and patients from different clinical backgrounds Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014